• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白与β-淀粉样蛋白的相互作用:结合及对淀粉样蛋白形成的抑制作用

Interaction of transthyretin with amyloid beta-protein: binding and inhibition of amyloid formation.

作者信息

Schwarzman A L, Goldgaber D

机构信息

Department of Psychiatry, School of Medicine, State University of New York at Stony Brook 11794-8101, USA.

出版信息

Ciba Found Symp. 1996;199:146-60; discussion 160-4. doi: 10.1002/9780470514924.ch10.

DOI:10.1002/9780470514924.ch10
PMID:8915609
Abstract

Aggregated amyloid beta-protein (A beta) is a key component of the amyloid depositions found in the brains of patients with Alzheimer's disease. In contrast, in cerebrospinal fluid (CSF), A beta is found in a soluble form. The analysis of complexes of A beta with CSF proteins in a KBr gradient revealed an association of A beta only with free proteins and not with lipoprotein particles. Transthyretin (TTR), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of A beta fibril formation. In physiological buffers and CSF, TTR exclusively decreased the level of A beta pentamers. Endogenous TTR-A beta complexes were detected in human CSF by immunoprecipitation. Using site-directed mutagenesis and computer-assisted modelling, we identified amino acid residues on the surface of the TTR monomer that interact with A beta. Specific TTR immunoreactivity was detected in multiple cortical neurons and astrocytes in the human brain. We propose that A beta binding proteins play a key role in the modulation of A beta aggregation and normally prevent amyloid formation in biological fluids and in the brain.

摘要

聚集的β-淀粉样蛋白(Aβ)是在阿尔茨海默病患者大脑中发现的淀粉样沉积物的关键成分。相比之下,在脑脊液(CSF)中,Aβ以可溶形式存在。在KBr梯度中对Aβ与脑脊液蛋白复合物的分析表明,Aβ仅与游离蛋白相关,而与脂蛋白颗粒无关。转甲状腺素蛋白(TTR)是脑脊液中的第二种主要蛋白,它与Aβ形成SDS稳定复合物,并显著降低Aβ纤维形成的速率。在生理缓冲液和脑脊液中,TTR专门降低Aβ五聚体的水平。通过免疫沉淀在人脑脊液中检测到内源性TTR-Aβ复合物。利用定点突变和计算机辅助建模,我们确定了TTR单体表面与Aβ相互作用的氨基酸残基。在人脑中多个皮质神经元和星形胶质细胞中检测到特异性TTR免疫反应性。我们认为,Aβ结合蛋白在调节Aβ聚集过程中起关键作用,通常可防止生物体液和大脑中淀粉样蛋白的形成。

相似文献

1
Interaction of transthyretin with amyloid beta-protein: binding and inhibition of amyloid formation.转甲状腺素蛋白与β-淀粉样蛋白的相互作用:结合及对淀粉样蛋白形成的抑制作用
Ciba Found Symp. 1996;199:146-60; discussion 160-4. doi: 10.1002/9780470514924.ch10.
2
Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants.重组甲状腺素运载蛋白变体的淀粉样变性和抗淀粉样变性特性
Amyloid. 2004 Mar;11(1):1-9. doi: 10.1080/13506120410001667458.
3
Transthyretin sequesters amyloid beta protein and prevents amyloid formation.转甲状腺素蛋白可隔离β淀粉样蛋白并防止淀粉样蛋白形成。
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8368-72. doi: 10.1073/pnas.91.18.8368.
4
Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro.转甲状腺素蛋白体外抑制β-淀粉样蛋白聚集的机制。
J Neurosci. 2013 Dec 11;33(50):19423-33. doi: 10.1523/JNEUROSCI.2561-13.2013.
5
The inhibition of cellular toxicity of amyloid-β by dissociated transthyretin.分离型转甲状腺素抑制淀粉样-β的细胞毒性。
J Biol Chem. 2020 Oct 9;295(41):14015-14024. doi: 10.1074/jbc.RA120.013440. Epub 2020 Aug 7.
6
Copper mediated amyloid-β binding to Transthyretin.铜介导的淀粉样蛋白-β与转甲状腺素蛋白结合。
Sci Rep. 2018 Sep 13;8(1):13744. doi: 10.1038/s41598-018-31808-5.
7
Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease.脑脊液转甲状腺素蛋白:衰老与晚发性阿尔茨海默病
J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):506-8. doi: 10.1136/jnnp.63.4.506.
8
Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.通过压力使α-突触核蛋白和转甲状腺素蛋白的淀粉样原纤维解离,揭示了它们的可逆性质以及水排斥腔的形成。
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9831-6. doi: 10.1073/pnas.1734009100. Epub 2003 Aug 4.
9
Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation.天然多酚抑制转甲状腺素蛋白(TTR)淀粉样纤维形成过程的不同步骤。
FEBS Lett. 2011 Aug 4;585(15):2424-30. doi: 10.1016/j.febslet.2011.06.030. Epub 2011 Jul 2.
10
Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.碘代二氟尼柳通过稳定转甲状腺素蛋白促进淀粉样β肽清除,减少其沉积,并改善阿尔茨海默病小鼠模型的认知缺陷。
J Alzheimers Dis. 2014;39(2):357-70. doi: 10.3233/JAD-131355.

引用本文的文献

1
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.在实验系统中增加淀粉样蛋白-β脑外排的方法。
J Alzheimers Dis. 2024;100(2):379-411. doi: 10.3233/JAD-240212.
2
Amyloid Disassembly: What Can We Learn from Chaperones?淀粉样蛋白解聚:我们能从伴侣蛋白中学到什么?
Biomedicines. 2022 Dec 17;10(12):3276. doi: 10.3390/biomedicines10123276.
3
Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology.淀粉样斑块的细胞外蛋白成分及其在阿尔茨海默病病理中的作用。
Mol Neurodegener. 2021 Aug 28;16(1):59. doi: 10.1186/s13024-021-00465-0.
4
Neuroprotection in early stages of Alzheimer's disease is promoted by transthyretin angiogenic properties.转甲状腺素的血管生成特性可促进阿尔茨海默病早期的神经保护。
Alzheimers Res Ther. 2021 Aug 24;13(1):143. doi: 10.1186/s13195-021-00883-8.
5
Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?转甲状腺素蛋白稳定化:阿尔茨海默病治疗的新兴策略?
Int J Mol Sci. 2020 Nov 17;21(22):8672. doi: 10.3390/ijms21228672.
6
Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer's Disease.未被发现的转甲状腺素蛋白作用:从一种转运蛋白到阿尔茨海默病的新治疗靶点。
Int J Mol Sci. 2020 Mar 18;21(6):2075. doi: 10.3390/ijms21062075.
7
Inhibition of amyloid beta fibril formation by monomeric human transthyretin.单体人转甲状腺素抑制淀粉样β纤维形成。
Protein Sci. 2018 Jul;27(7):1252-1261. doi: 10.1002/pro.3396. Epub 2018 Mar 14.
8
Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.经化学处理的血浆β淀粉样蛋白是一种用于筛查脑淀粉样蛋白沉积的潜在血液生物标志物。
Alzheimers Res Ther. 2017 Mar 22;9(1):20. doi: 10.1186/s13195-017-0248-8.
9
Resveratrol administration increases Transthyretin protein levels ameliorating AD features- importance of transthyretin tetrameric stability.白藜芦醇给药可提高转甲状腺素蛋白水平,改善阿尔茨海默病特征——转甲状腺素蛋白四聚体稳定性的重要性。
Mol Med. 2016 Oct;22:597-607. doi: 10.2119/molmed.2016.00124. Epub 2016 Jun 30.
10
Transthyretin Suppresses Amyloid-β Secretion by Interfering with Processing of the Amyloid-β Protein Precursor.转甲状腺素蛋白通过干扰淀粉样β蛋白前体的加工过程来抑制淀粉样β蛋白的分泌。
J Alzheimers Dis. 2016 Apr 8;52(4):1263-75. doi: 10.3233/JAD-160033.